“New Strategies in Treating Respiratory Failure—NIV & HFNO as Complementary Therapies”
Saxe Communications & Philips Healthcare* present…“New Strategies in Treating Respiratory Failure—NIV & HFNO as complementary therapies”
Noninvasive ventilation (NIV) or the delivery of positive pressure ventilation delivered through a has become more common as its benefits are increasingly recognized. NIV has proven efficacy for hypercapnic respiratory failure, especially that due to COPD exacerbations. High-flow nasal cannula (HFNO) comprises an air/oxygen blender, an active humidifier, a single heated circuit, and a nasal cannula. HFNO has shown promise to treat hypoxic respiratory failure. This webinar will explore a new strategy in the treatment of respiratory conditions and discussion on how HFNO with NIV enables a complementary approach for weaning efficiency.
Learning Objectives | At the completion of this activity, the participant will be able to:
- Discuss indications for NIV and HFNO
- Compare and contrast physiologic actions of NIV and HFNO
- Demonstrate how HFNO and NIV can work in complementary fashion
Presenter: Nicholas S. Hill, M.D. | Chief, Pulmonary & Critical Care, and Sleep Division | Tufts Medical Center | Boston
Target audience: Nurses & Respiratory therapists
Continuing Education: Nurses & Respiratory Therapists
This program has been approved for 1.0 contact hour of Continuing Respiratory Care Education (CRCE) credit by the American Association of Respiratory Care, 9425 N. MacArthur Blvd. Suite 100, Irving, TX 75063.
This education activity is approved for 1.0 contact hour. Provider approved by California Board of Nursing, Provider # 14477 and the Florida Board of Nursing Provider # 50-17032. Support for this educational activity has been provided by Philips.
Questions should be addressed by Philips via Emily Eberly: 513-579-0800 | Producer@WebinarCreativeTechnology.com
* NOTE: This is a contracted supplier-sponsored webinar. HealthTrust has not approved and/or endorsed the content. This program may contain the mention of products, services, drugs or brands presented in a case study or comparative format. Such examples are intended for educational and informational purposes and should not be perceived as a HealthTrust endorsement of any particular upplier, product, service, drug, brand or approach.